REDHILL BIOPHARMA LTD. Current Derivative Financial Liabilities
REDHILL BIOPHARMA LTD. (RDHL) had Current Derivative Financial Liabilities of $11.00 thousand as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2025-09-05
- 2025-06-30: Current Derivative Financial Liabilities $11.00K.
- 2024-12-31: Current Derivative Financial Liabilities $1.42M.
- 2024-06-30: Current Derivative Financial Liabilities $2.54M.
- 2023-12-31: Current Derivative Financial Liabilities $741.00K.
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2025-06-30 | $11.00K 6-K · filed 2025-09-05 |
| 2024-12-31 | $1.42M 6-K · filed 2025-09-05 |
| 2024-06-30 | $2.54M 6-K · filed 2024-08-29 |
| 2023-12-31 | $741.00K 20-F · filed 2025-04-10 |